Niagen Bioscience, Inc. NAGE
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2007-06-25
Niagen Bioscience, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,116,178 | $8.5M | 3.65% |
| CITADEL ADVISORS LLC | 674,809 | $2.2M | 0.79% |
| RENAISSANCE TECHNOLOGIES LLC | 659,584 | $2.1M | 0.77% |
| AQR CAPITAL MANAGEMENT LLC | 472,056 | $1.5M | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 275,423 | $878,599 | 0.32% |
| D. E. Shaw & Co., Inc. | 99,938 | $318,802 | 0.12% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.